Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 87879

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 04, 2021
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Dr. Reddy's Laboratories, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Atorvastatin Calcium Tablets, USP 10 mg*, Rx Only, 500 count bottle, Mfd By: Dr. Reddy's Laboratories Limited, Bachupally 500 090, India, NDC 55111-121-05.

D-0599-2021
Recall number
D-0599-2021
Initiated
May 04, 2021
Classification
Class III
Status
Terminated
Quantity
2980 500 count -bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

Code information

Lot # C905063, Exp 07/2021

Distribution pattern

Distributed Nationwide in the USA